share_log

HC Wainwright & Co. Maintains Neutral on Co-Diagnostics, Raises Price Target to $3

Benzinga ·  Nov 13, 2023 23:43

HC Wainwright & Co. analyst Yi Chen maintains Co-Diagnostics (NASDAQ:CODX) with a Neutral and raises the price target from $2 to $3.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment